表紙：検体有効性検査市場規模、シェア、成長分析、製品別、タイプ別、エンドユーザー別、地域別 - 産業予測、2025年～2032年

市場調査レポート

商品コード

1764800

検体有効性検査市場規模、シェア、成長分析、製品別、タイプ別、エンドユーザー別、地域別 - 産業予測、2025年～2032年

Specimen Validity Testing Market Size, Share, and Growth Analysis, By Product (Products, Services), By Type (Laboratory Testing, Rapid/PoC Testing), By End User, By Region - Industry Forecast 2025-2032

出版日: 2025年07月04日
発行: SkyQuest
ページ情報: 英文 188 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 782,598円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 915,492円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,048,386円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=147.66円

全表示
概要
目次

概要

サンプル依頼リストに入れる

検体有効性検査の世界市場規模は、2023年に24億米ドルと評価され、2024年の25億6,000万米ドルから2032年には42億3,000万米ドルに成長し、予測期間（2025年～2032年）のCAGRは6.5％で成長する見通しです。

世界の検体有効性検査市場は、職場、法執行機関、ヘルスケア、スポーツなどさまざまな分野で、正確で信頼性が高く、改ざんできない薬物検査のニーズが高まっていることを背景に、大きな成長を遂げています。法執行機関は、違法薬物使用と闘うために、コカインやマリファナを含む薬物乱用を特定するためにこれらの検査方法を採用しています。さらに、政府による従業員スクリーニングの義務化が、市場の需要を後押ししています。技術の進歩は重要な役割を果たしており、人工知能や機械学習などの技術革新は、異常検体を検出するための予測モデルの開発に使用されています。さらに、ブロックチェーン技術は違法物質の追跡と検査結果の改ざん防止に採用され、IoT対応デバイスは検体の完全性に影響する環境要因を分析し、最終的に検査プロセスの正確性と安全性を高める。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
最近の市場動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 企業の詳細
- 製品ポートフォリオ分析
- 企業のセグメント別シェア分析
- 収益の前年比比較（2022-2024年）

主要企業プロファイル

Abbott.（U.S.）
Thermo Fisher Scientific Inc.（U.S.）
Puritan Medical Products（U.S.）
BD（U.S.）
Laboratory Corporation of America Holdings（U.S.）
Lucence Health Inc.（Singapore）
Hardy Diagnostics（U.S.）
BTNX（Canada）
Formlabs（U.S.）
Medline Industries, Inc.（U.S.）
VIRCELL S.L.（Spain）
HiMedia Laboratories（India）
Titan Biotech（India）
McDermott Will & Emery（U.S.）
Miraclean Technology Co. Ltd（China）
DiaSorin Molecular LLC（U.S.）

結論と提言

Product Code: SQMIG35E2056

Global Specimen Validity Testing Market size was valued at USD 2.4 billion in 2023 and is poised to grow from USD 2.56 billion in 2024 to USD 4.23 billion by 2032, growing at a CAGR of 6.5% during the forecast period (2025-2032).

The global specimen validity testing market is witnessing significant growth driven by the increasing need for precise, reliable, and tamper-proof drug testing across various sectors, including workplace, law enforcement, healthcare, and sports. Law enforcement agencies employ these testing methods to identify substance abuse, including cocaine and marijuana, to combat illegal drug use. Furthermore, government mandates for employee screenings are propelling market demand. Technological advancements play a crucial role, with innovations such as artificial intelligence and machine learning used to develop predictive models for detecting abnormal specimens. Additionally, blockchain technology is employed for tracking illegal substances and preventing test result tampering, while IoT-enabled devices analyze environmental factors affecting specimen integrity, ultimately enhancing the accuracy and security of testing processes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Specimen Validity Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Specimen Validity Testing Market Segments Analysis

Global Specimen Validity Testing Market is segmented by Product, Type, End User and region. Based on Product, the market is segmented into Products and Services. Based on Type, the market is segmented into Laboratory Testing and Rapid/PoC Testing. Based on End User, the market is segmented into Workplaces, Drug Screening Laboratories, Criminal Justice and Law Enforcement Agencies, Pain Management Centers, Drug Rehabilitation Centers and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Specimen Validity Testing Market

The Global Specimen Validity Testing market is primarily propelled by the increasing need for precise and dependable drug testing solutions. This rising demand is particularly evident in sectors such as sports drug testing, workplace testing, and the criminal justice system. Furthermore, heightened awareness regarding the adverse effects of drug use, coupled with the necessity for trustworthy testing methods, significantly contributes to the market's expansion. As organizations and institutions strive to ensure compliance and safety, the emphasis on effective specimen validity testing continues to grow, enhancing the industry's overall momentum and driving innovation within the sector.

Restraints in the Global Specimen Validity Testing Market

The Global Specimen Validity Testing market faces several constraints, primarily due to the high costs associated with the necessary equipment, reagents, and operational procedures. Laboratories must invest significantly in advanced tools and temperature monitoring devices to ensure the authenticity and accuracy of samples. These sophisticated instruments not only incur high initial procurement costs but also demand regular maintenance, calibration, and periodic replacement, adding to overall expenses. Additionally, the need for skilled and trained personnel to operate these systems escalates labor and training costs, creating further financial burdens for laboratories engaged in specimen validity testing.

Market Trends of the Global Specimen Validity Testing Market

The Global Specimen Validity Testing (SVT) market is witnessing a significant upward trend, fueled by advancements in diagnostic technology, including AI, machine learning, and the Internet of Things (IoT). These innovations enhance the effectiveness and user-friendliness of SVT, thereby bolstering confidence in drug testing across various sectors such as workplaces, healthcare, law enforcement, and sports. Furthermore, cutting-edge tools like biosensors and sophisticated chemical assays enable more precise detection of specimen adulteration, dilution, or substitution. As these technological developments continue to progress, the SVT market is poised for robust growth, meeting increasing demands for reliable and accurate testing solutions.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technology Analysis
Case Studies

Global Specimen Validity Testing Market Size by Product & Service & CAGR (2025-2032)

Market Overview
Products
- Reagents, Calibrators, and Controls
- Assay Kits
- Disposables
Services

Global Specimen Validity Testing Market Size by Type & CAGR (2025-2032)

Market Overview
Laboratory Testing
Rapid/PoC Testing

Global Specimen Validity Testing Market Size by End User & CAGR (2025-2032)

Market Overview
Workplaces
Drug Screening Laboratories
Criminal Justice and Law Enforcement Agencies
Pain Management Centers
Drug Rehabilitation Centers
Other End Users

Global Specimen Validity Testing Market Size & CAGR (2025-2032)

North America (Product & Service, Type, End User)
- US
- Canada
Europe (Product & Service, Type, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product & Service, Type, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product & Service, Type, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product & Service, Type, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Abbott. (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Puritan Medical Products (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BD (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Laboratory Corporation of America Holdings (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lucence Health Inc. (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hardy Diagnostics (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BTNX (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Formlabs (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medline Industries, Inc. (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
VIRCELL S.L. (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HiMedia Laboratories (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Titan Biotech (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
McDermott Will & Emery (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Miraclean Technology Co. Ltd (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DiaSorin Molecular LLC (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

検体有効性検査市場規模、シェア、成長分析、製品別、タイプ別、エンドユーザー別、地域別 - 産業予測、2025年～2032年

Specimen Validity Testing Market Size, Share, and Growth Analysis, By Product (Products, Services), By Type (Laboratory Testing, Rapid/PoC Testing), By End User, By Region - Industry Forecast 2025-2032

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

検体有効性検査市場規模：製品別& CAGR（2025年～2032年）

検体有効性検査市場規模：タイプ別& CAGR（2025年～2032年）

検体有効性検査市場規模：エンドユーザー別& CAGR（2025年～2032年）

検体有効性検査市場規模：地域別& CAGR（2025年～2032年）